Group 1 - The shareholders Qingdao Jinshi and Changxia Jinshi plan to reduce their holdings in Airo Energy by up to 800,000 shares each, representing 0.50% of the total share capital, within three months after 15 trading days from the announcement [1][2] - Shanghai Zhongdian Investment plans to reduce its holdings by up to 1,600,000 shares, which is 1% of the total share capital, within the same timeframe [1][2] - The total number of shares to be reduced by all shareholders amounts to 3,200,000 shares, which does not affect the control of the listed company [2] Group 2 - As of the announcement date, Qingdao Jinshi and Changxia Jinshi each hold 4,562,520 shares, accounting for 2.85% of the total share capital, with specific shares becoming tradable on January 3, 2025, and May 6, 2025 [2] - Shanghai Zhongdian holds 6,388,320 shares, representing 3.99% of the total share capital, with the same tradable dates as above [2] - Airo Energy was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 3, 2024, with an initial public offering price of 55.66 yuan per share, and is currently in a state of price decline [2] Group 3 - Airo Energy raised a total of 2,226.40 million yuan from its initial public offering, with a net amount of 1,988.07 million yuan after deducting issuance costs, exceeding the original plan by 1,179.35 million yuan [3] - The funds raised are intended for projects including the expansion of energy storage batteries and inverters, the construction of a smart energy R&D center, and the establishment of an overseas marketing and service system [3] - The total issuance costs amounted to 238.33 million yuan, with underwriting fees constituting a significant portion [3]

Core Points - Gannee Pharmaceutical (甘李药业) announced the completion of a share reduction plan by its shareholder, Beijing Xutong Hongda Technology Co., Ltd. (旭特宏达), which reduced its holdings by 6,010,622 shares, representing 1% of the company's total share capital [1][2] - The share reduction occurred between April 22, 2025, and April 30, 2025, with a price range of 44.85 to 49.81 yuan per share, totaling approximately 290.35 million yuan [1][2] - After the reduction, Xutong Hongda holds 35,473,235 shares, accounting for 5.90% of the total share capital [2] Shareholder Information - Before the reduction, Xutong Hongda and its concerted party, Gan Zhongru, held a combined total of 247,127,614 shares, which is 41.11% of the total share capital [3] - Xutong Hongda owned 41,483,857 shares (6.90%), while Gan Zhongru held 205,643,757 shares (34.21%) [3] - Gan Zhongru is the largest shareholder of Gannee Pharmaceutical, and Xutong Hongda is the second largest [3] Fundraising Activities - Gannee Pharmaceutical went public on June 29, 2020, raising a total of 2.545 billion yuan, with a net amount of 2.441 billion yuan after expenses [4] - The funds raised were allocated for various projects, including marketing network construction and product registration in the U.S. [4] - In 2023, the company issued 28,508,550 shares at a price of 27.12 yuan per share, raising approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [5]

Group 1 - The major shareholder, Zhejiang Chuchu Equity Investment Partnership, plans to reduce its stake in Chuhuan Technology by up to 2,395,605 shares, representing 3% of the total share capital after excluding repurchased shares, within three months starting from May 27, 2025 [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 798,535 shares to be sold via centralized bidding and 1,597,070 shares via block trading [1] - Chuhuan Technology assures that this reduction will not lead to a change in control or affect the company's governance structure and ongoing operations [1] Group 2 - In Q1 2025, Chuhuan Technology reported revenue of 24.23 million yuan, a year-on-year decrease of 74.05%, and a net profit attributable to shareholders of 3.90 million yuan, down 57.18% [2] - The company's cash flow from operating activities was 20.26 million yuan, compared to 11.41 million yuan in the same period last year [2] - Chuhuan Technology was listed on the Shenzhen Stock Exchange on July 25, 2022, raising a total of 460 million yuan, with net proceeds of 382.57 million yuan intended for various projects including air pollution control equipment production lines and a technology research center [3][4]

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

关于持股5%以上股东减持股份的预披露公告 持股5%以上股东安吉浙楚股权投资合伙企业（有限合伙）保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001336 证券简称：楚环科技 公告编号：2025-018 杭州楚环科技股份有限公司 特别提示： 持有杭州楚环科技股份有限公司（以下简称"公司"或"本公司"）股份4,991,578股（占剔除公司回购专用 证券账户股份后的总股本的6.25%）的大股东安吉浙楚股权投资合伙企业（有限合伙）（以下简称"浙 楚投资"）计划自本公告披露日起15个交易日后的3个月内（即2025年5月27日至2025年8月26日），以集 中竞价交易方式、大宗交易方式合计减持本公司股份不超过2,395,605股（占剔除公司回购专用证券账户 股份后的总股本的3%）。其中，以集中竞价交易方式减持股份数量不超过798,535股（即不超过剔除公 司回购专用证券账户股份后的总股本的1%），以大宗交易方式减持股份数量不超过1,597,070股（即不 超 ...

欣天科技(300615.SZ)公告称，持股9.15%的股东薛枫因个人资金需要，计划在未来3个月内，以集中竞 价或大宗交易方式合计减持公司股份不超过5,804,076股，占公司总股本的3%。减持期间为2025年5月27 日至8月26日。 ...

新亚电子（605277）公告，董事陈华辉、杨文华、陈景淼及董事会秘书HUANG JUAN计划自公告发布 之日起15个交易日后的3个月内，通过集中竞价方式减持股份。其中，陈华辉拟减持不超过59万股，占 公司总股本的0.18%；杨文华拟减持不超过60万股，占公司总股本的0.19%；陈景淼拟减持不超过45万 股，占公司总股本的0.14%；HUANG JUAN拟减持不超过55万股，占公司总股本的0.17%。减持原因均 为个人资金需求。 ...

尽管减持新规已经相当严格，但在实际执行过程中，仍存在一些情况使得减持行为对市场造成较大压力。一方面，在某些特殊情况下，股东仍能找到减持 的途径。比如，虽然规定了控股股东、实际控制人在破发、破净、分红不达标等情形下不得通过集中竞价交易或者大宗交易减持股份，但对于一些非控股 股东、持股比例较小的股东，限制相对较弱。他们可能会在市场波动时，大量减持股份，对股价造成冲击。 多年来上证指数始终难以实现实质性的突破，构建起持续向上的牛市行情。在这一现象背后，隐藏着诸多复杂且深层次的因素，其中股东减持问题显得尤 为突出，即便在减持新规发布后，依然存在一些值得关注的情况。 过去，减持制度存在诸多漏洞，使得部分股东有机会"钻空子"，实现无限减持。例如，在早期，对于股东减持的限制较少，无论是减持的时间、数量还是 信息披露等方面，都缺乏严格的规范。这就导致一些股东，尤其是原始股东，他们的持股成本极低，在公司上市后，随时可以减持套现，获取巨额财富。 即便后来出台了一些规定，如大股东减持需提前披露等，但由于规则不够细化，仍无法有效遏制不合理的减持行为。 2024年5月24日晚间，证监会正式发布《上市公司股东减持股份管理暂行办法》及相关 ...

万通发展（600246）公告，公司计划自公告披露之日起15个交易日后至2025年8月26日，通过集中竞价 交易方式，按市场价格减持不超过1916.91万股已回购股份，占公司总股本的1%。减持计划具体情况 为：减持主体为北京万通新发展集团股份有限公司回购专用证券账户，持股数量为4567.27万股，持股 比例为2.3826%。减持价格将根据出售时的二级市场价格确定，减持所得资金将用于补充公司流动资 金。预计减持完成后，公司回购专用证券账户股份将由4567.27万股减少至2650.36万股，占公司总股本 的比例由2.3826%减少至1.3826%。本次减持计划不会导致公司控制权发生变化，不会对公司的经营、 财务和未来发展产生重大影响。 ...

1. 阿莱德（301419.SZ）：股东吴靖计划15个交易日后3个月内，通过集中竞价和/或大宗交易减持不超 过1.50%的公司股份。 2. 大位科技（600589.SH）：股东高大鹏计划15个交易日后3个月内，通过集中竞价及大宗交易减持不 超过3%的公司股份。 4. 东方创业（600278.SH）：副总经理蒋远扬女士已通过集中竞价方式完成减持8,300股，占公司总股本 0.0009%。 5. 海泰科（301022.SZ）：股东新麟三期通过集中竞价减持524,800股，占公司总股本0.6192%，减持计 划时间已届满。 6. 航天软件（688562.SH）：股东宁波星东计划通过集中竞价减持不超过1.00%的公司股份。 7. 红墙股份（002809.SZ）：股东广东省科技创业投资有限公司、何元杰女士及韩强先生减持计划实施 完毕，分别减持1%、0.132%及0.021%的公司股份。 8. 华昌达（300278.SZ）：股东深圳塔桥投资合伙企业（有限合伙）计划15个交易日后3个月内，通过集 中竞价减持不超过0.703%的公司股份。 9. 华胜天成（600410.SH）：多位董监高计划15个交易日后3个月内，通过集中竞 ...